Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/1999
12/22/1999EP0733033B1 Pharmaceutically active substituted aromatic compounds
12/22/1999EP0731795B1 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
12/22/1999EP0684953A4 Adenosine kinase inhibitors comprising lyxofuranosyl derivatives.
12/22/1999CN1239510A Compsns. and methods for treating disease states with myeloid progenitor inhibitory factor-1(MPIF-1), monocyte colony inhibitory factor (M-CIF) and macrophage inhibitory factor-4(MIP-4)
12/21/1999US6005117 Imino compounds, process for their preparation and their use as victronectin antagonists
12/21/1999US6005000 5,5-Disubstituted-3, 4-dihydroxy-2(5H)-furanones and methods of use therefor
12/21/1999US6004994 Antiinflammatory agents, cyclooxygenase inhibitors and analgesics
12/21/1999US6004987 Use of ligands which are specific for RXR receptors
12/21/1999US6004983 Analgesics; antiinflammatory, antiarthritic and antidiabetic agents
12/21/1999US6004974 Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-α]pyridines
12/21/1999US6004961 1,4-disubstituted piperazines
12/21/1999US6004948 Derivatives of benzosulphonamides as inhibitors of the enzyme cyclooxygenase II
12/21/1999US6004942 Administering viral vector to joint comprising nucleic acid sequence encoding polypeptide; gene expression
12/21/1999US6004813 Il-6 activity inhibitor
12/21/1999US6004792 Amino acid sequence of enzyme which controls intracellular lipids; for antiinflammatory/antiproliferative/ anticarcinogenic agents; diagnosis and prevention of autoimmune, gastrointestinal, and cardiovascular disorders
12/21/1999US6004560 Obtaining a liquid by boiling bupleurum scorzonerifolium willd, radix lastidis indigotica and folium lastidis for a long time in water, and then mixing the liquid thus obtained with vitamin c
12/21/1999US6004559 Plant material is extracted using an organic solvent, preferably acetone, then saturated with reducing agent acids to reduce toxic ndga quinone, which naturally occurs in the plant material, to ndga; antiinflammatory, antiviral agents
12/21/1999US6004556 Staphylococcus aureus RSBU-1
12/21/1999US6004552 Administration of a monoclonal antibody capable of binding to a human cd40 antigen located on the surface of a human b cell, wherein the binding of the antibody to the cd40 antigen prevents the growth or differentiation of the b cell
12/21/1999CA2135850C Esculetin derivatives, and method for manufacture thereof, use thereof, and pharmaceutical composition
12/21/1999CA2026974C 3-aroyl-2-oxindole-1-carboximides
12/17/1999CA2235420A1 Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
12/16/1999WO1999064426A1 Heterobicyclic and tricyclic nitric oxide synthase inhibitors
12/16/1999WO1999064423A1 Furopyridine derivatives and their therapeutical use
12/16/1999WO1999064415A1 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
12/16/1999WO1999064414A1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
12/16/1999WO1999064406A1 A process for the preparation of macrocyclic metalloprotease inhibitors
12/16/1999WO1999064401A2 Imidazolyl derivatives and their use as somatostatin receptor ligands
12/16/1999WO1999064400A1 INHIBITORS OF p38
12/16/1999WO1999064390A1 Phenylalanine derivatives as integrin inhibitors
12/16/1999WO1999064070A1 Prevention and treatment of sepsis
12/16/1999WO1999064069A1 Antibodies to cytokines in the prevention and treatment of inflammatory bowel disease
12/16/1999WO1999064021A1 hCEPR RECEPTOR
12/16/1999WO1999063998A1 Novel use of hiv protease inhibiting compounds
12/16/1999WO1999063987A1 N-acetyl 3-chloroprocainamide, acid addition salts thereof, and methods of use
12/16/1999WO1999063982A1 Wound treatment through inhibition of adenosine diphosphate ribosyl transferase
12/16/1999WO1999063939A2 Multibinding inhibitors of cyclooxygenase-2
12/16/1999WO1999043651A3 Inhibitors of phospholipase enzymes
12/16/1999WO1999041375A3 Human receptor proteins
12/16/1999WO1999041368A3 Optimization of immunomodulatory properties of genetic vaccines
12/16/1999WO1998024902A8 Adaptor protein frs2 and related products and methods
12/16/1999CA2334990A1 Novel use of hiv protease inhibiting compounds
12/16/1999CA2334979A1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
12/16/1999CA2334945A1 Imidazolyl derivatives
12/16/1999CA2334788A1 N-acetyl 3-chloroprocainamide, acid addition salts thereof, and methods of use
12/16/1999CA2333691A1 Heterobicyclic and tricyclic nitric oxide synthase inhibitors
12/16/1999CA2333629A1 Furopyridine derivatives and their therapeutical use
12/16/1999CA2333551A1 A process for the preparation of macrocyclic metalloprotease inhibitors
12/16/1999CA2329160A1 Wound treatment through inhibition of adenosine diphosphate ribosyl transferase
12/16/1999CA2320290A1 Multibinding inhibitors of cyclooxygenase-2
12/15/1999EP0963984A1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
12/15/1999EP0963200A2 Methods and compositions for inhibition of angiogenesis
12/15/1999EP0963197A1 Guanylhydrazones useful for treating diseases associated with t cell activation
12/15/1999EP0765305B1 Anti-inflammatory compounds
12/15/1999EP0749434B1 Benzothiophene, benzofuran and indolethiazepinones, oxazepinones and diazepinones as inhibitors of cell adhesion and as inhibitors of hiv
12/15/1999EP0664703B1 Methods of combating (pneumocystis carinii) pneumonia and compounds useful therefor
12/15/1999EP0643585B1 The use of Lipoprotein Associated Coagulation Inhibitor (LACI) for the preparation of a medicament for the treatment of acute or chronic inflammation.
12/15/1999EP0642504B1 (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them
12/15/1999EP0638079B1 Deazaaminopterins for treatment of inflammation
12/15/1999CN1238781A Heptapeptide oxytocin analofues
12/15/1999CN1238689A Vitronectin receptor antagonists
12/14/1999US6002014 Selectively inhibiting the action of cox-2; treating inflammation
12/14/1999US6001987 Isolated nucleotide sequences associated with Multiple sclerosis
12/14/1999US6001972 Splicing variant of the epstein-barr virus-induced G-protein coupled receptor
12/14/1999US6001885 Retinoid inhibition of expression of VEGF
12/14/1999US6001876 Administering analogs of 4-aminobutyric acid to treat pain in mammals
12/14/1999US6001833 Novel piperazine derivatives which are substituted in the 2-position by an indolylmethyl radical and in which the nitrogen in the 4-position of the piperazine ring forms part of a urea structure bearing a benzylaminoethyl substituent
12/14/1999US6001832 [1,2,4]triazolo[4,3-a]quinoxalinone derivatives, their preparation and use
12/14/1999US6001830 Heterocyclic compounds
12/14/1999US6001819 Bacterial inhibition with an oligosaccharide compound
12/14/1999US6001802 Antiproliferative agents
12/14/1999US6001651 Antisense modulation of LFA-3
12/14/1999US6001623 Polynucleotide sequence coding a human enzymatic polypeptide; for developing treatments and diagnostic assays for disease
12/14/1999US6001358 Useful for treatment of autoimmune diseases
12/14/1999CA2186526C Method and product for regulating cell responsiveness to external signals
12/14/1999CA2181150C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
12/14/1999CA2138873C Composition against acne insuring the simultaneous treatment of the superficial and deep layers of the skin, and its use
12/14/1999CA2081028C Cd2 binding domain of lymphocyte function associated antigen 3
12/14/1999CA2065150C Inhibitors of thrombin
12/14/1999CA2010636C Substituted pyrroles
12/09/1999WO1999063087A1 G-protein coupled receptor, named 2871 receptor
12/09/1999WO1999063080A1 HUMAN HOMOLOGUE OF UNC-53 PROTEIN OF $i(C. ELEGANS)
12/09/1999WO1999062908A2 Cell adhesion-inhibiting antinflammatory compounds
12/09/1999WO1999062901A1 Aromatic amine derivatives as pharmaceutical agents
12/09/1999WO1999062885A1 Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents
12/09/1999WO1999062884A1 Pyrazoline derivatives, their preparation and application as medicaments
12/09/1999WO1999062883A1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors
12/09/1999WO1999062875A1 Nitric oxide synthase inhibitors
12/09/1999WO1999062557A1 Composition for the transdermal administration of non-steroidal anti-inflammatory drugs
12/09/1999WO1999062549A1 Method of inhibiting angiogenesis and tumor growth and preventing tumor growth and metastases
12/09/1999WO1999062543A1 Composition based on pentoxifylline and anticytokin
12/09/1999WO1999062541A1 Immunosuppressants containing clusterins
12/09/1999WO1999062540A1 Use of cyclosporins in the treatment of inflammatory autoimmune diseases
12/09/1999WO1999062525A1 Compositions comprising methotrexate and pentostatin for treating rheumatoid arthritis
12/09/1999WO1999062524A1 Aminosugar, glycosaminoglycan, and s-adenosylmethionine composition for the treatment and repair of connective tissue
12/09/1999WO1999062523A1 Bridged indenopyrrolocarbazoles
12/09/1999WO1999062518A1 PYRROLO[2,3d]PYRIMIDINE COMPOSITIONS AND THEIR USE
12/09/1999WO1999062507A1 Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease
12/09/1999WO1999062498A1 Spill resistant pharmaceutical compositions
12/09/1999WO1999049885A3 The use of isolated domains of type iv collagen to modify cell and tissue interactions
1 ... 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 ... 1272